Yunzhe Sun

Title: Yunzhe Sun: Innovator in Pharmaceutical Formulation

Introduction

Yunzhe Sun is a notable inventor based in Nanjing, Jiangsu Province, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His work focuses on improving the stability and efficacy of drug formulations, which is crucial for patient treatment.

Latest Patents

Yunzhe Sun holds a patent for an "Aripiprazole injectable suspension formulation having prolonged shelf life." This invention pertains to a pharmaceutical formulation that enhances the shelf life of aripiprazole, a medication used in treating schizophrenia and related disorders. The formulation not only improves the stability of the drug but also provides methods for its effective use in clinical settings.

Career Highlights

Yunzhe Sun is associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical sciences. His innovative approach to drug formulation has positioned him as a key figure in the industry, contributing to advancements in medication delivery systems.

Collaborations

Yunzhe has collaborated with notable colleagues such as Qi Peng and Cheng-Gang Lin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.

Conclusion

Yunzhe Sun's contributions to pharmaceutical formulation, particularly through his patented work on aripiprazole, highlight his role as an influential inventor in the field. His ongoing efforts continue to impact the treatment of schizophrenia and improve patient outcomes.